Related Experiment Video
Updated: May 23, 2026
07:23
Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
Published on: December 3, 2016
Muenke syndrome associated with multiple osteochondromas
Simon G Talbot1, Joseph Upton, Gary F Rogers
1Department of Plastic Surgery, Children's Hospital Boston and Harvard Medical School, Boston, Massachusetts, USA.
The Journal of Craniofacial Surgery
|March 27, 2012
Summary
Muenke syndrome, a condition involving FGFR3 Pro250Arg mutation, typically presents with craniosynostosis and hearing loss. This report details a rare case of Muenke syndrome associated with multiple osteochondromas, highlighting a potential link between FGFR3 and bone tumor development.
Area of Science:
- Genetics
- Orthopedics
- Developmental Biology
Background:
- Muenke syndrome is characterized by the FGFR3 Pro250Arg mutation, leading to craniosynostosis, hearing loss, and diverse bone anomalies.
- While FGFR3 mutations impact bone development, the occurrence of bony tumors in Muenke syndrome is exceptionally rare.
Observation:
- This study presents a patient with a molecularly confirmed diagnosis of Muenke syndrome.
- The patient exhibited multiple osteochondromas in both the upper and lower extremities, a presentation documented only once previously in association with Muenke syndrome.
Findings:
- The co-occurrence of Muenke syndrome and multiple osteochondromas suggests a potential, albeit infrequent, association.
- Altered fibroblast growth factor receptor 3 (FGFR3) expression is implicated in the pathogenesis of osteochondromas.
Implications:
- This case underscores the importance of considering osteochondroma development in patients diagnosed with Muenke syndrome.
- Understanding the role of FGFR3 in chondrocyte biology may offer insights into the mechanisms underlying osteochondroma formation in this genetic condition.
Related Concept Videos
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:24Bone Formation by Endochondral Ossification
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...